A Study of TCD601 in the Induction of Tolerance in de Novo Liver Transplantation
Condition: Liver Transplantation Interventions: Biological: TCD601; Biological: Cyclophosphamide; Drug: TAC; Drug: MMF; Drug: Corticosteroids Sponsor: ITB-Med LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2023 Category: Research Source Type: clinical trials
Registry 17-009: Multi-Institutional Study Examining Patients With HCC Undergoing Liver Transplantation
Condition: Hepatocellular Carcinoma Intervention: Sponsors: Federico Aucejo; Ohio State University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2023 Category: Research Source Type: clinical trials
A Study of TCD601 in the Induction of Tolerance in de Novo Liver Transplantation
Condition: Liver Transplantation Interventions: Biological: TCD601; Biological: Cyclophosphamide; Drug: TAC; Drug: MMF; Drug: Corticosteroids Sponsor: ITB-Med LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2023 Category: Research Source Type: clinical trials
Registry 17-009: Multi-Institutional Study Examining Patients With HCC Undergoing Liver Transplantation
Condition: Hepatocellular Carcinoma Intervention: Sponsors: Federico Aucejo; Ohio State University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2023 Category: Research Source Type: clinical trials
A Study of TCD601 in the Induction of Tolerance in de Novo Liver Transplantation
Condition: Liver Transplantation Interventions: Biological: TCD601; Biological: Cyclophosphamide; Drug: TAC; Drug: MMF; Drug: Corticosteroids Sponsor: ITB-Med LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2023 Category: Research Source Type: clinical trials
Registry 17-009: Multi-Institutional Study Examining Patients With HCC Undergoing Liver Transplantation
Condition: Hepatocellular Carcinoma Intervention: Sponsors: Federico Aucejo; Ohio State University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2023 Category: Research Source Type: clinical trials
A Study of TCD601 in the Induction of Tolerance in de Novo Liver Transplantation
Condition: Liver Transplantation Interventions: Biological: TCD601; Biological: Cyclophosphamide; Drug: TAC; Drug: MMF; Drug: Corticosteroids Sponsor: ITB-Med LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2023 Category: Research Source Type: clinical trials
Registry 17-009: Multi-Institutional Study Examining Patients With HCC Undergoing Liver Transplantation
Condition: Hepatocellular Carcinoma Intervention: Sponsors: Federico Aucejo; Ohio State University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2023 Category: Research Source Type: clinical trials
A Study of TCD601 in the Induction of Tolerance in de Novo Liver Transplantation
Condition: Liver Transplantation Interventions: Biological: TCD601; Biological: Cyclophosphamide; Drug: TAC; Drug: MMF; Drug: Corticosteroids Sponsor: ITB-Med LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2023 Category: Research Source Type: clinical trials
Registry 17-009: Multi-Institutional Study Examining Patients With HCC Undergoing Liver Transplantation
Condition: Hepatocellular Carcinoma Intervention: Sponsors: Federico Aucejo; Ohio State University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2023 Category: Research Source Type: clinical trials
A Study of TCD601 in the Induction of Tolerance in de Novo Liver Transplantation
Condition: Liver Transplantation Interventions: Biological: TCD601; Biological: Cyclophosphamide; Drug: TAC; Drug: MMF; Drug: Corticosteroids Sponsor: ITB-Med LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2023 Category: Research Source Type: clinical trials
